Notice of Intent.pdf
PDF 27 KB Posted
- Solicitation number
- 75N98026Q00912
About this file
This is a Notice of Intent to award a firm-fixed-price purchase order for specialized genetic testing services. The National Institutes of Health (NIH), specifically the National Human Genome Research Institute (NHGRI) Undiagnosed Diseases Program (UDP), intends to award the contract to Greenwood Genetic Center Inc. under solicitation number 75N98026Q00912. This acquisition represents a continuation of genetic testing services previously provided under NIH PO 75N92025P00400.
The UDP requires specialized laboratory testing to support diagnostic evaluations and research activities for patients with complex, chronic, and previously undiagnosed medical conditions enrolled under clinical protocol 15-HG-0130. The testing services must address rare genetic, epigenetic, metabolic, and lysosomal disorders to help identify disease etiologies, establish accurate diagnoses, and discover novel genetic conditions. Although this is not a competitive solicitation, small businesses including 8(a) firms, service-disabled veteran-owned small businesses, HUBZone small businesses, small disadvantaged businesses, veteran-owned small businesses, and women-owned small businesses may submit written capability statements demonstrating their ability to perform the requirement by August 4, 2026 at 5:00 p.m. EDT to david.shen@nih.gov. Award is anticipated approximately ten days after the notice date unless the Government determines another vendor possesses the requisite capability.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Notice of Intent: Specialized genetic testing for undiagnosed diseases
(75N98026Q00912)
In accordance with FAR Part 6.302-1, the National Institutes of Health intends to award a Firm- Fixed-Price Purchase Order to Greenwood Genetic Center Inc. This acquisition is a continuation of genetic testing services from NIH PO 75N92025P00400.
The National Human Genome Research Institute (NHGRI) Undiagnosed Diseases Program (UDP) evaluates individuals with complex, chronic, and previously undiagnosed medical conditions.
Patients enrolled under NHGRI clinical protocol 15-HG-0130 typically have undergone extensive diagnostic evaluations prior to referral to the National Institutes of Health (NIH) Clinical Center and frequently present with multisystem disorders requiring advanced diagnostic testing. The UDP seeks to identify disease etiologies, establish accurate diagnoses, discover novel genetic conditions, and advance scientific understanding of rare disorders. Specialized laboratory testing is required to support diagnostic evaluations and ongoing research activities involving rare genetic, epigenetic, metabolic, and lysosomal disorders.
This notice is not a request for competitive quotes. However, any available small businesses (e.g., 8(a), service-disabled veteran owned small business, HUBZone small business, small disadvantaged business, veteran-owned small business, and women-owned small business) as stated herein may submit a written capability statement that clearly supports and demonstrates their ability to perform the requirement. A determination by the Government to compete this proposed award based upon responses to this notice is solely within the discretion of the Government.
It is anticipated that an award will be issued approximately ten (10) days after the date of this notice unless the Government determines that another vendor has the capability to meet this requirement.
Please email responses to david.shen@nih.gov no later than 5:00 p.m. EDT on August 4, 2026.
mailto:david.shen@nih.gov
File details come from the government source that posted it. Updated .